1. Home
  2. AACG vs NEPH Comparison

AACG vs NEPH Comparison

Compare AACG & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATA Creativity Global

AACG

ATA Creativity Global

N/A

Current Price

$0.82

Market Cap

41.5M

Sector

Real Estate

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.66

Market Cap

49.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AACG
NEPH
Founded
1999
1997
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.5M
49.4M
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
AACG
NEPH
Price
$0.82
$3.66
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
4.6K
★ 18.3K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1000.00
EPS
N/A
★ 0.12
Revenue
N/A
★ $18,789,000.00
Revenue This Year
N/A
$17.81
Revenue Next Year
N/A
$15.90
P/E Ratio
★ N/A
$32.42
Revenue Growth
N/A
★ 32.67
52 Week Low
$0.74
$2.66
52 Week High
$1.50
$6.42

Technical Indicators

Market Signals
Indicator
AACG
NEPH
Relative Strength Index (RSI) N/A 37.63
Support Level N/A $3.19
Resistance Level N/A $3.78
Average True Range (ATR) 0.00 0.23
MACD 0.00 -0.08
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
AACG
NEPH

About AACG ATA Creativity Global

ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments of the company are (i) Overseas art study services (ii) Other educational services and (iii) Other services. Majority of its revenue comes from Overseas art study services.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: